Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been dosed in the FOCUS ...
Abstract: The robust adaptive beamforming design problem based on estimation of the signal-of-interest (SOI) steering vector is considered in the paper. The common criteria to find the best estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results